×
About 1,161 results

ALLMedicine™ Ca 19-9 Center

Research & Reviews  571 results

High detection rates of pancreatic cancer across stages by plasma assay of novel methyl...
https://doi.org/10.1158/1078-0432.CCR-20-0235
Clinical Cancer Research : an Official Journal of the Ame... Majumder S, Taylor W et. al.

Feb 17th, 2021 - We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case-control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. Thirteen MDMs(GRIN2D, CD...

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787803
Disease Markers; Wen Z, Huang Y et. al.

Jan 25th, 2021 - Lung cancer (LC) is top-ranked in cancer incidence and is the leading cause of cancer death globally. Combining serum biomarkers can improve the accuracy of LC diagnosis. The identification of the best potential combination of traditional tumor ma...

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802224
BMC Cancer; Hussung S, Akhoundova D et. al.

Jan 12th, 2021 - Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS...

Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer.
https://doi.org/10.1053/j.gastro.2021.01.001
Gastroenterology Modi S, Kir D et. al.

Jan 8th, 2021 - Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer.|2021|Modi S,Kir D,Saluja AK,|

Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasm...
https://doi.org/10.1016/j.thromres.2020.12.018
Thrombosis Research; Mattila N, Hisada Y et. al.

Jan 1st, 2021 - Pancreatic ductal adenocarcinoma (PDAC) is associated with a hypercoagulable state and high mortality. Increases in the plasma levels of tumor marker carbohydrate antigen (CA) 19-9 are used in diagnosis and follow-up but have also been reported to...

see more →

Clinicaltrials.gov  583 results

High detection rates of pancreatic cancer across stages by plasma assay of novel methyl...
https://doi.org/10.1158/1078-0432.CCR-20-0235
Clinical Cancer Research : an Official Journal of the Ame... Majumder S, Taylor W et. al.

Feb 17th, 2021 - We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case-control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. Thirteen MDMs(GRIN2D, CD...

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787803
Disease Markers; Wen Z, Huang Y et. al.

Jan 25th, 2021 - Lung cancer (LC) is top-ranked in cancer incidence and is the leading cause of cancer death globally. Combining serum biomarkers can improve the accuracy of LC diagnosis. The identification of the best potential combination of traditional tumor ma...

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802224
BMC Cancer; Hussung S, Akhoundova D et. al.

Jan 12th, 2021 - Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS...

Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer.
https://doi.org/10.1053/j.gastro.2021.01.001
Gastroenterology Modi S, Kir D et. al.

Jan 8th, 2021 - Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer.|2021|Modi S,Kir D,Saluja AK,|

Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasm...
https://doi.org/10.1016/j.thromres.2020.12.018
Thrombosis Research; Mattila N, Hisada Y et. al.

Jan 1st, 2021 - Pancreatic ductal adenocarcinoma (PDAC) is associated with a hypercoagulable state and high mortality. Increases in the plasma levels of tumor marker carbohydrate antigen (CA) 19-9 are used in diagnosis and follow-up but have also been reported to...

see more →

News  5 results

Pancreatic Adenocarcinoma: Update on Neoadjuvant and Adjuvant Treatment
https://www.mdedge.com/hematology-oncology/article/160757/gi-oncology/pancreatic-adenocarcinoma-update-neoadjuvant-and/page/0/3

Mar 27th, 2018 - Neoadjuvant Therapy Case Continued The patient is referred to oncology. Blood work reveals a CA 19-9 level of 100 U/mL (reference range < 35 U/mL) and a staging CT scan of the chest reveals a benign-appearing 3-mm nodule (no prior imaging for comp.

In Pancreatic Cancer, If CA 19-9 Is Up, Then Chemo First
https://www.medscape.com/viewarticle/854166

Nov 8th, 2015 - Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA 19-9 biomarker should receive chemotherapy firs...

In Pancreatic Cancer, If CA 19-9 Is Up, Then Chemo First
https://www.staging.medscape.com/viewarticle/854166

Nov 8th, 2015 - Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA 19-9 biomarker should receive chemotherapy firs...

Biomarker panel identified patients with pancreatic cancer
https://www.mdedge.com/hematology-oncology/article/82480/gastroenterology/biomarker-panel-identified-patients-pancreatic
Amy Karon

May 20th, 2014 - A biomarker panel distinguished individuals with pancreatic cancer from those who were healthy, had benign pancreatic cysts, or had chronic pancreatitis with about 90% accuracy, based on analyses of two cohorts. The panel, which tests for the know.

Chemotherapy of Advanced Small-bowel Adenocarcinoma: A Multicenter AGEO Study
https://www.medscape.com/viewarticle/727621_4

Discussion In this retrospective multicenter study, the largest reported to date, PS and baseline CEA and CA 19-9 levels were the only independent prognostic factors for PFS and/or OS. PS had previously been identified as an independent prognostic...

see more →

Patient Education  2 results see all →